These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32416786)

  • 1. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
    Williams B; Zhang Y
    Lancet; 2020 May; 395(10238):1671-1673. PubMed ID: 32416786
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
    Henry RA
    CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 4. Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
    Liu D; Li YZ; Wu H
    J Hypertens; 2020 Jun; 38(6):1191-1192. PubMed ID: 32371813
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 6. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic.
    Augoustides JGT
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1717-1719. PubMed ID: 32360010
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Birnbaum RA
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427430
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Haug G; Eapen MS; Sohal SS
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427429
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Lubel J; Garg M
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427428
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.
    Jarcho JA; Ingelfinger JR; Hamel MB; D'Agostino RB; Harrington DP
    N Engl J Med; 2020 Jun; 382(25):2462-2464. PubMed ID: 32356625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].
    Mareev YV; Mareev VY
    Kardiologiia; 2020 Apr; 60(4):4-9. PubMed ID: 32394850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
    Vaduganathan M; Solomon SD
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427431
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
    Henry BM; Benoit S; Lippi G; Benoit J
    Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
    N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
    Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.
    Tedeschi S; Giannella M; Bartoletti M; Trapani F; Tadolini M; Borghi C; Viale P
    Clin Infect Dis; 2020 Jul; 71(15):899-901. PubMed ID: 32339215
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 18. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Quinn KL; Fralick M; Zipursky JS; Stall NM
    CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
    [No Abstract]   [Full Text] [Related]  

  • 19. Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.
    Ekiz T; Kara M; Özcan F; Ricci V; Özçakar L
    Am J Phys Med Rehabil; 2020 Oct; 99(10):880-882. PubMed ID: 32657817
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?
    Volpe M; Battistoni A
    Int J Cardiol; 2020 Dec; 321():150-154. PubMed ID: 32738257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.